DOCSLIB.ORG

Hematology & Oncology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY page 1 Hematology & Oncology How to Use the Workbook with the Videos Using this table as a guide, read the Facts in First Aid for the USMLE Step 1 2016, watch the corresponding First Aid Express 2016 videos, and then answer the workbook questions. Facts in First Aid for Corresponding First Aid Workbook the USMLE Step 1 2016 Express 2016 videos questions 378.1–381.1 Anatomy (2 videos) 1–10 381.2–385.2 Physiology (2 videos) 11–14 386.1–404.2 Pathology (9 videos) 15–30 405.1–413.4 Pharmacology (3 videos) 31–35 Copyright © 2016 by MedIQ Learning, LLC All rights reserved v1.0 page 2 First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY Questions ANATOMY 1. Define the following terms. (p 378) A. Anisocytosis _______________________________________________________________ B. Poikilocytosis _______________________________________________________________ C. Thrombocytopenia __________________________________________________________ 2. What do the dense granules of platelets contain? (p 378) ________________________________ 3. What do the α-granules of platelets contain? (p 378) ____________________________________ 4. List the types of white blood cells in order of decreasing prevalence. (pp 378) ________________ ______________________________________________________________________________ 5. What conditions can cause hypersegmentation of neutrophils? (p 378) _____________________ ______________________________________________________________________________ 6. CD14 is a cell surface marker for which cell type? (p 379) _______________________________ 7. What five conditions can cause eosinophilia? (p 379) ___________________________________ ______________________________________________________________________________ 8. What molecules are released by basophils? (p 379) ____________________________________ ______________________________________________________________________________ 9. B lymphocytes are produced in the _______________ (bone marrow/thymus) and mature in the _______________ (bone marrow/thymus). T lymphocytes are produced in the _______________ (bone marrow/thymus) and mature in the _______________ (bone marrow/thymus). (p 380) 10. What type of cell has an off-center nucleus, abundant RER, and a clock-face chromatin dis- tribution? (p 381) ______________________________________________________________ Copyright © 2016 by MedIQ Learning, LLC All rights reserved v1.0 page 3 First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY PHYSIOLOGY 11. Why are Rh-negative mothers given RhoGAM? (p 382) _________________________________ ______________________________________________________________________________ 12. In the chart, check which coagulation factors are in the intrinsic vs. the extrinsic coagulation pathways. (p 384) Factor Extrinsic Pathway Intrinsic Pathway Both Pathways I II V VII VIII IX X XI XII 13. Which factors are vitamin K dependent? How does warfarin inhibit the activation of these factors? (p 384) ________________________________________________________________________ ______________________________________________________________________________ 14. Describe the four steps of primary hemostasis and platelet plug formation. (p 385) ____________ ______________________________________________________________________________ ______________________________________________________________________________ PATHOLOGY 15. Identify each cell type and its associated pathology. (pp 386-387) A. B. C. D. E. F. A. _______________________________ D. ______________________________ B. _______________________________ E. ______________________________ C. _______________________________ F. ______________________________ Copyright © 2016 by MedIQ Learning, LLC All rights reserved v1.0 page 4 First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY 16. In α-thalassemia, what is the condition called when all four α-globin genes are deleted? When three are deleted? When one or two are deleted? (p 388) ________________________________ ______________________________________________________________________________ 17. Indicate whether the lab findings in the chart are elevated, decreased, or normal. (pp 388, 389, 391, 393) Anemia of Iron Pregnancy/ Hemo- Lab Value Chronic Deficiency OCPs chromatosis Disease Ferritin Serum iron Transferrin % Transferrin 18. In lead poisoning what enzymes are affected and what substrates are accumulated? (p 389) ___ ______________________________________________________________________________ 19. What clinical manifestations do folate deficiency and vitamin B12 deficiency have in common? What sets them apart? (p 390) __________________________________________________________ 20. What are four causes of aplastic anemia? (p 391) ______________________________________ ______________________________________________________________________________ 21. Match the intrinsic hemolytic normocytic anemia with its characteristic. (p 392) _____ A. G6PD deficiency 1. GLU LYS mutation _____ B. HbC defect 2. GLU VAL mutation _____ C. Hereditary spherocytosis 3. Heinz bodies _____ D. Paroxysmal nocturnal hemoglobinuria 4. Howell-Jolly bodies _____ E. Pyruvate kinase deficiency 5. Increased incidence of acute leukemias _____ F. Sickle cell anemia 6. Rigid RBCs 22. Which autoimmune hemolytic anemias are warm and which are cold? (p 393) _______________ ______________________________________________________________________________ 23. What are the “5 P’s” of acute intermittent porphyria? (p 395) _____________________________ ______________________________________________________________________________ Copyright © 2016 by MedIQ Learning, LLC All rights reserved v1.0 First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY page 5 24. Indicate whether the lab findings in the chart are elevated, decreased, or normal. (pp 396-398) Platelet Bleeding Disorder PT PTT Count Time DIC Glanzmann thrombasthenia Hemophilia TTP Vitamin K deficiency von Willebrand disease 25. Which type of Hodgkin lymphoma is equally prevalent in men and women? (p 399) ___________ ______________________________________________________________________________ 26. What type of cell is shown by the arrow in the image? In what condition is this cell seen? (p 399) ________________________________________ ________________________________________ ________________________________________ 27. Match the disease with the genetic translocation most closely associated with it. (pp 400-403) _____ A. Burkitt lymphoma 1. t(8;14) _____ B. Chronic myelogenous leukemia 2. t(9;22) _____ C. Follicular lymphoma 3. t(11;14) _____ D. M3 AML 4. t(14;18) _____ E. Mantle cell lymphoma 5. t(15;17) 28. What will serum protein electrophoresis reveal in a patient with multiple myeloma? What will be seen in the urine? (p 401) _________________________________________________________ 29. What are the four major groups of leukemia? Which type is at risk for DIC upon initiation of treatment and why? (p 402) _______________________________________________________ _______________________________________________________________________________ _______________________________________________________________________________ 30. Indicate whether the lab findings in the chart are elevated, decreased, or normal. (p 404) Chronic Myeloproliferative Platelets RBCs WBCs Disorder CML Essential thrombocytosis Myelofibrosis Polycythemia vera Copyright © 2016 by MedIQ Learning, LLC All rights reserved v1.0 page 6 First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY PHARMACOLOGY 31. What is the mechanism of action of heparin? How is overdose treated? (p 406) ______________ ______________________________________________________________________________ 32. What is the mechanism of action of warfarin? How is overdose treated? (p 406) _____________ ______________________________________________________________________________ 33. Indicate how the drugs in the chart affect the lab findings. (pp 406-407) Bleeding Platelet Drug PT PTT Time Count Aspirin Clopidogrel/abciximab Heparin Warfarin 34. Match the drug with its target. (pp 409-413) _____ A. Abciximab 1. ADP receptor (platelets) _____ B. Clopidogrel 2. B cells (CD20) _____ C. Etoposide 3. bcr-abl tyrosine kinase _____ D. 5-Fluorouracil 4. Estrogen receptor _____ E. Imatinib 5. Glycoprotein IIb/IIIa receptor _____ F. Rituximab 6. HER2 (erb-B2) _____ G. Tamoxifen 7. Plasminogen _____ H. tPA 8. Thymidylate synthase _____ I. Trastuzumab 9. Topoisomerase II _____ J. Vincristine 10. Tubulin 35. Match the patient with the drug he or she is most likely taking. (pp 409-410) _____ A. Patient preparing for bone marrow transplantation has 1. Bleomycin PFTs consistent with restrictive lung disease 2. Busulfan _____ B. Patient with colon cancer has myelosuppression 3. Cyclophosphamide not reversible with leucovorin 4. Doxorubicin _____ C. Patient with non-Hodgkin lymphoma is having 5. 5-Fluorouracil hemorrhagic cystitis 6. Methotrexate _____ D. Patient with leukemia is having myelosuppression reversible with leucovorin _____ E. Patient with solid tumor is having dilated cardiomyopathy _____ F. Patient with testicular cancer has PFTs consistent with restrictive lung disease Copyright © 2016 by MedIQ Learning, LLC All rights reserved v1.0 First Aid Express 2016 workbook: HEMATOLOGY & ONCOLOGY page 7 Answers ANATOMY 1. A. Anisocytosis: Cells vary in size. B. Poikilocytosis: Cells vary in shape. C. Thrombocytopenia: Decreased number of platelets. 2. ADP and calcium. 3. von Willebrand factor, fibrinogen, and fibronectin.
Recommended publications
  • Modelling of Red Blood Cell Morphological and Deformability Changes During In-Vitro Storage

    Modelling of Red Blood Cell Morphological and Deformability Changes During In-Vitro Storage

    applied sciences Article Modelling of Red Blood Cell Morphological and Deformability Changes during In-Vitro Storage Nadeeshani Geekiyanage 1 , Emilie Sauret 1,*, Suvash Saha 2 , Robert Flower 3 and YuanTong Gu 1 1 School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane City, QLD 4000, Australia; [email protected] (N.G.); [email protected] (Y.G.) 2 School of Mechanical and Mechatronic Engineering, University of Technology Sydney (UTS), Ultimo, NSW 2007, Australia; [email protected] 3 Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, QLD 4059, Australia; [email protected] * Correspondence: [email protected] Received: 28 February 2020; Accepted: 27 April 2020; Published: 4 May 2020 Featured Application: Red blood cell (RBC) storage lesion is a critical issue facing transfusion treatments, and significant changes in RBC morphology and deformability are observed due to the storage lesion. RBCs require high deformability to sustain in-vivo circulation, and impaired deformability leads to several post-transfusion adverse outcomes. Therefore, improved understanding of the interrelation between the morphological and deformability changes and the quality and viability of the stored RBCs is essential to prevent or reduce the transfusion related adverse outcomes. To support this requisite, the influence on RBC deformability due to several aspects of the storage lesion, namely, the changes in cell morphology, surface area and volume, RBC membrane biomechanics, and cytoskeletal structural integrity are explored numerically in this study. Abstract: Storage lesion is a critical issue facing transfusion treatments, and it adversely affects the quality and viability of stored red blood cells (RBCs).
  • Thrombotic Microangiopathy Score As a New Predictor for Neurologic Outcome in Patients Undergoing Targeted Temperature Management After Out-Of-Hospital Cardiac Arrest

    Thrombotic Microangiopathy Score As a New Predictor for Neurologic Outcome in Patients Undergoing Targeted Temperature Management After Out-Of-Hospital Cardiac Arrest

    Thrombotic Microangiopathy Score as a New Predictor for Neurologic Outcome in Patients Undergoing Targeted Temperature Management After Out-of-hospital Cardiac Arrest Taeyoung Kong Yonsei University College of Medicine Hye Sun Lee Yonsei University College of Medicine Soyoung Jeon Yonsei University College of Medicine Jong Wook Lee Konyang University Hospital Hyun Soo Chung Yonsei University College of Medicine Sung Phil Chung Yonsei University College of Medicine Je Sung You ( [email protected] ) Yonsei University College of MedicineGangnam Severance Hospital https://orcid.org/0000-0002-2074- 6745 Original research Keywords: Out-of-hospital cardiac arrest, Targeted temperature management, Thrombotic microangiopathy score, Mortality, Predictor, Schistocytes Posted Date: July 8th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-40096/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/21 Abstract Background: Given the morphological characteristics of schistocytes, thrombotic microangiopathy (TMA) score can be benecial as it can be quickly and serially measured without additional effort or costs. This study aimed to investigate whether the serial TMA scores until 48 h post admission are associated with clinical outcomes in patients undergoing targeted temperature management (TTM) after out-of-hospital cardiac arrest (OHCA). Methods:We retrospectively evaluated a cohort of 185 patients using a prospective registry. We analyzed the TMA score at admission and after 12, 24, and
  • Morphological Study of Human Blood for Different Diseases

    Morphological Study of Human Blood for Different Diseases

    Research Article ISSN: 2574 -1241 DOI: 10.26717/BJSTR.2020.30.004893 Morphological Study of Human Blood for Different Diseases Muzafar Shah1*, Haseena1, Kainat1, Noor Shaba1, Sania1, Sadia1, Akhtar Rasool2, Fazal Akbar2 and Muhammad Israr3 1Centre for Animal Sciences & Fisheries, University of Swat, Pakistan 2Centre for Biotechnology and Microbiology, University of Swat, Pakistan 3Department of Forensic Sciences, University of Swat, Pakistan *Corresponding author: Muzafar Shah, Centre for Animal Sciences & Fisheries, University of Swat, Pakistan ARTICLE INFO ABSTRACT Received: August 25, 2020 The aim of our study was the screening of blood cells on the basis of morphology for different diseased with Morphogenetic characters I e. ear lobe attachment, clinodactyly Published: September 07, 2020 and tongue rolling. For this purpose, 318 blood samples were collected randomly. Samples were examined under the compound microscopic by using 100x with standard Citation: Muzafar Shah, Haseena, method. The results show 63 samples were found normal while in 255 samples, different Kainat, Noor Shaba, Sania, Sadia, et al. types of morphological changes were observed which was 68.5%, in which Bite cell 36%, Morphological Study of Human Blood for Elliptocyte 34%, Tear drop cell 30%, Schistocyte 26%, Hypochromic cell 22.5%, Irregular Different Diseases. Biomed J Sci & Tech Res contracted cell 16%, Echinocytes 15.5%, Roleaux 8%, Boat shape 6.5%, Sickle cell 5%, Keratocyte 4% and Acanthocytes 1.5%. During the screening of slides, bite cell, elliptocyte, tear drop cell, schistocytes, hypochromic cell, irregular contracted cells were found 30(1)-2020.Keywords: BJSTR.Human MS.ID.004893. blood; Diseases; frequently while echinocytes, boat shape cell, acanthocytes, sickle cells and keratocytes Morphological; Acanthocytes; Keratocyte were found rarely.
  • Detection of Anemia Disease Using Pso Algorithm and Lbp Texture Analysis

    Detection of Anemia Disease Using Pso Algorithm and Lbp Texture Analysis

    International Journal of Pure and Applied Mathematics Volume 120 No. 6 2018, 15-26 ISSN: 1314-3395 (on-line version) url: http://www.acadpubl.eu/hub/ Special Issue http://www.acadpubl.eu/hub/ DETECTION OF ANEMIA DISEASE USING PSO ALGORITHM AND LBP TEXTURE ANALYSIS 1S. Dhanasekaran M.E., 2Dr. N. R. Shanker Ph.D., 1Research Scholar, 2Professor/ Supervisor-Aalim Muhammed Salegh College of Engineering Department of Electronics and Communication Engineering PRIST University, Thanjavur, Tamilnadu Abstract: Nowadays, patients with anemia disease oxygen from the lungs to different parts of the body and present in the world increased by around 60-70% also to carrying maximum carbon dioxide (CO2) from respectively. The digital image processing technique has different parts of the body to lungs. successfully characterised to introduce new methods for Functional near-infrared spectroscopy (fNIRS) is disease analysis has lead to reliable systems and more utilised to differentiatethe patient with schizophrenia, and accurate for anemia disease diagnosis. This paper gives the healthy persons are based on the support vector an algorithm for the automatic detection of anemia machine (SVM) and principal component analysis disease through palm image. For solving such issues, a (PCA). Firstly, PCA is utilized to select the features on PSO algorithm and LBP texture analysis are applied for oxygenated haemoglobin (oxy-Hb) signals from the classification of palm images. There are several features different channel fNIRS data. Secondly, aextraction is are consider based on statistical analysis, i.e. mean, based on SVM is planned to separate the schizophrenia variance and entropy have been extracted. The from a healthy people.
  • TOPIC 5 Lab – B: Diagnostic Tools & Therapies – Blood & Lymphatic

    TOPIC 5 Lab – B: Diagnostic Tools & Therapies – Blood & Lymphatic

    TOPIC 5 Lab – B: Diagnostic Tools & Therapies – Blood & Lymphatic Disorders Refer to chapter 17 and selected online sources. Refer to the front cover of Gould & Dyer for normal blood test values. Complete and internet search for videos from reliable sources on blood donations and blood tests. Topic 5 Lab - A: Blood and Lymphatic Disorders You’ll need to refer to an anatomy & physiology textbook or lab manual to complete many of these objectives. Blood Lab Materials Prepared slides of normal blood Prepared slides of specific blood pathologies Models of formed elements Plaque models of formed elements Blood typing model kits Blood Lab Objectives – by the end of this lab, students should be able to: 1. Describe the physical characteristics of blood. 2. Differentiate between the plasma and serum. 3. Identify the formed elements on prepared slides, diagrams and models and state their main functions. You may wish to draw what you see in the space provided. Formed Element Description / Function Drawing Erythrocyte Neutrophil s e t y c Eosinophils o l u n a r Basophils Leukocytes G e Monocytes t y c o l u n Lymphocytes a r g A Thrombocytes 4. Define differential white blood cell count. State the major function and expected range (percentage) of each type of white blood cell in normal blood. WBC Type Function Expected % Neutrophils Eosinophils Basophils Monocytes Lymphocytes 5. Calculation of the differential count? 6. Define and use in proper context: 1. achlorhydria 5. amyloidosis 2. acute leukemia 6. anemia 3. agnogenic myeloid metaplasia 7. autosplenectomy 4. aleukemic leukemia 8. basophilic stippling 9.
  • Clinical Hematology 1

    Clinical Hematology 1

    CLINICAL HEMATOLOGY 1 CLINICAL HEMATOLOGY Editor Gamal Abdul Hamid, MD,PhD Associate Professor Faculty of Medicine and Health Sciences University of Aden CLINICAL HEMATOLOGY 2 PREFACE Clinical Hematology, first edition is written specifically for medical students, the clinician and resident doctors in training and general practioner. It is a practical guide to the diagnosis and treatment of the most common disorders of red blood cells, white blood cells, hemostasis and blood transfusion medicine. Each disease state is discussed in terms of the pathophysiology, clinical and paraclinical features which support the diagnosis and differential diagnosis. We bring together facts, concepts, and protocols important for the practice of hematology. In addition this book is also supported with review questions and quizzes. G.A-H 2012 CLINICAL HEMATOLOGY 3 CONTENTS Preface 1. Hematopoiesis 7 2. Anemia 26 3. Iron Deficiency Anemia 32 4. Hemolytic Anemia 41 5. Sickle Cell Hemoglobinopathies 49 6. Thalassemia 57 7. Hereditary Hemolytic Anemia 63 8. Acquired Hemolytic Anemia 68 9. Macrocytic Anemia 75 10. Bone Marrow Failure, Panctopenia 87 11. Spleen 95 12. Acute Leukemia 99 13. Chronic Myeloproliferative Disorders 125 14. Chronic Lymphoproliferative Disorders 137 15. Malignant Lymphoma 147 16. Multiple Myeloma and Related Paraproteinemia 171 17. Hemorrhagic Diseases 179 18. Transfusion Medicine 201 19. Bone Marrow Transplantations 214 CLINICAL HEMATOLOGY 4 Appendices: I. Hematological Tests and Normal Values 221 II. CD Nomenclature for Leukocytes Antigen 226 III. Cytotoxic Drugs 228 IV. Drugs Used in Hematology 230 Glossary 232 Answers 246 Bibliography 247 CLINICAL HEMATOLOGY 5 CLINICAL HEMATOLOGY 6 HEMATOPOIESIS 1 All of the cells in the peripheral blood have finite life spans and thus must be renewed continuously.
  • Ghid Incepator Al Celulelor Sanguine.Pdf

    Ghid Incepator Al Celulelor Sanguine.Pdf

    A BEGINNER’S GUIDE TO BLOOD CELLS A Beginner’s Guide to Blood Cells 2nd Edition Barbara J. Bain MB BS FRACP FRCPath Reader in Diagnostic Haematology, Department of Haematology St Mary’s Hospital Campus, Imperial College, St Mary’s Hospital, London © 1996, 2004 by Blackwell Publishing Ltd Blackwell Publishing, Inc., 350 Main Street, Malden, Massachusetts 02148-5020, USA Blackwell Publishing Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK Blackwell Publishing Asia Pty Ltd, 550 Swanston Street, Carlton, Victoria 3053, Australia The right of the Author to be identified as the Author of this Work has been asserted in accordance with the Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. First published 1996 Second edition 2004 Library of Congress Cataloging-in-Publication Data Bain, Barbara J. A beginner’s guide to blood cells / Barbara J. Bain. – 2nd ed. p. ; cm. Includes index. ISBN 1-4051-2175-0 1. Hematology–Handbooks, manuals, etc. 2. Blood cell–Handbooks, manuals, etc. [DNLM: 1. Blood Cells–physiology–Handbooks. 2. Blood Cells Count–methods– Handbooks. 3. Blood Cells–pathology–Handbooks. WH 39 B 162b 2004] I. Title. RB45.B268 2004 616.1¢5–dc22 2004001756 ISBN 1-4051-2175-0 A catalogue record for this title is available from the British Library Set in 9.5 on 13 pt Trump by SNP Best-set Typesetter Ltd., Hong Kong Printed and bound in India by Replica Press Pvt.
  • Developing a Computer-Based Information System to Improve the Diagnosis of Blood Anemia

    Developing a Computer-Based Information System to Improve the Diagnosis of Blood Anemia

    I I Developing a Computer-based Information System to Improve the Diagnosis of Blood Anemia By Bashar Abdallah Issa Khawaldeh Supervisor Dr. Basim Alhadidi This Thesis is submitted to the Department of Computer Information Systems, Faculty of Information Technology, Middle East University in partial fulfillment for the requirements for the degree of Master Degree in Computer Information System. Department of Computer Information Systems Faculty of Information Technology Middle East University (May 201 3) Amman – Jordan II III IV V VI ACKNOWLEDGMENTS I would like to thank my supervisor Dr. Basim Alhadidi for his support, encouragement, proofreading of thesis drafts, and helping me throughout my thesis, and so directing to the right track of Image processing. I thank the Information Technology Faculty members at the Middle East University for Graduate Studies; I thank my father and my mother for their continued support during my study. VII DEDICATION All praise belongs to Allah and all thanks to Allah. I dedicate this work to Parents, brothers, sisters, relatives, friends, and to all those who helped, supported and taught me. VIII Table of Contents Developing a Computer- based Information System to Improve the Diagnosis of Blood Anemia .…. I ………………………………….……..…................... .. ...... ………………...………………………..…….………. II Authorization Statement ………………………………………………….…………...………………………...…..…….……. III Examination Committee Decision ………………..…………………...…………………………………...……...…..…... IV Declaration …………………………………………………………………………………………………………………………....
  • Namib La University of Science and Technology

    Namib La University of Science and Technology

    nAmIB lA UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF BIOMEDICAL SCIENCES QUALIFICATION CODE: SOBBMS LEVEL: 6 COURSE CODE: HAM210S COURSE NAME: HAEMATOLOGY 1 SESSION: JUNE 2016 PAPER: THEORY DURATION: 3 HOURS MARKS: 100 FIRST OPPORTUNITY EXAMINATION QUESTION PAPER EXAMINER($) MR.MARTIN GONZO MODERATOR: MR. MUNYARADZI MUKESI INSTRUCTIONS 1. Answer ALL the questions. 2. Write clearly and neatly. 3. Number the answers clearly. PERMISSIBLE MATERIALS THIS QUESTION PAPER CONSISTS OF 7 PAGES (Including this front page} SECTION A [25] MULTIPLE CHOICE QUESTIONS QUESTION 1 [20] Answer ALL questions. Each correct answer is worth ONE mark. 1.1. Which of the following is TRUE for haemopoiesis? (1) a) In the first few weeks of development the long bones are the main site of haemopoiesis b) In adult life all the bone marrow is haemopoietic c) During childhood there is progressive fatty replacement of ma rrow in the long bones d) In adult life haemopoietic marrow is confined to the central skeleton only e) Red marrow forms only red blood cells 1.2. A full blood count was done and the results were as follow: red blood cells 2.86 X1012/L, red cell distribution width 23% and the mean cell volume 65 fl. Select the expected red blood cell morphologies for the above results: (1) a) Severe anisocytosis and spherocytosis b) Howell-Jolly bodies and anisocytosis c) Microcytes with anisocytosis d) Microcytosis with normal size red blood cells e) Microcytosis and target cells 1.3. Juvenile red blood cells are reticulocytes.
  • Plasmapheresis in Sepsis-Induced Thrombotic Microangiopathy

    Plasmapheresis in Sepsis-Induced Thrombotic Microangiopathy

    CASE REPORT Plasmapheresis in Sepsis-induced Thrombotic Microangiopathy: A Case Series Sushmita RS Upadhya1, Chakrapani Mahabala2, Jayesh G Kamat3, Jayakumar Jeganathan4, Sushanth Kumar5, Mayur V Prabhu6 ABSTRACT Introduction: Cytokines and granulocyte elastase produced in sepsis cleave a disintegrin and metalloprotease with thrombospondin type I motif 13 (ADAMTS13) and deplete its levels. By this mechanism, sepsis results in microangiopathic hemolytic anemia (MAHA) with thrombocytopenia. Hence, the hypothesis is that plasmapheresis may help in sepsis-induced thrombotic microangiopathy (sTMA), by removing the factors responsible for low levels of ADAMTS13. In tropical countries like India, the contribution of sepsis to intensive care unit (ICU) mortality is high; and hence, it is essential to look out for newer modalities of sepsis treatment. There is abundant literature on the use of plasmapheresis in sepsis but data on its use in sTMA are limited, thus necessitating further research in this field. Case description: This case series studies the outcomes of five patients admitted with sTMA in the ICU and attempts to evaluate the effectiveness of plasmapheresis in improving their outcomes. All patients diagnosed with sTMA and treated with plasmapheresis, between January 2016 and August 2018 at our tertiary care center, were selected for the study. The diagnosis of sepsis was based on sepsis-3 definition. Results: Four different gram-negative organisms were found to have caused MAHA, with the commonest source being either urinary tract infection (UTI) or lower respiratory tract infection. Three of five patients required hemodialysis and two had disseminated intravascular coagulation (DIC). All five had good outcome and recovered well from the acute episode post plasmapheresis.
  • Lipopolysaccharide-Induced Hemolysis Is Abolished by Inhibition of Thrombin Generation but Not Inhibition of Platelet Aggregation

    Lipopolysaccharide-Induced Hemolysis Is Abolished by Inhibition of Thrombin Generation but Not Inhibition of Platelet Aggregation

    Inflammation, Vol. 42, No. 5, October 2019 ( # 2019) DOI: 10.1007/s10753-019-01038-6 ORIGINAL ARTICLE Lipopolysaccharide-Induced Hemolysis Is Abolished by Inhibition of Thrombin Generation but Not Inhibition of Platelet Aggregation Stephan Brauckmann,1,2 Katharina Effenberger-Neidnicht,2 Michael Nagel,3 Christian Mayer,3 Jürgen Peters,1 and Matthias Hartmann 1,4 Abstract—In human sepsis, hemolysis is an independent predictor of mortality, but the mech- anisms evoking hemolysis have not been fully elucidated. Therefore, we tested the hypoth- eses that (1) lipopolysaccharide (LPS)-induced hemolysis is dependent on thrombin gener- ation or platelet aggregation and (2) red cell membranes are weakened by LPS. Anesthetized male Wistar rats were subjected to LPS or vehicle for 240 min. The effects of hemostasis inhibition on LPS-induced hemolysis were investigated by use of the thrombin inhibitor argatroban or the platelet function inhibitor eptifibatide. Free hemoglobin concentration, red cell membrane stiffness and red cell morphological changes were determined by spectropho- tometry, atomic force microscopy, and light microscopy. Efficacy of argatroban and eptifibatide was assessed by rotational thrombelastometry and impedance aggregometry, respectively. LPS markedly increased free hemoglobin concentration (20.8 μmol/l ± 3.6 vs. 3.5 ± 0.3, n =6, p < 0.0001) and schistocytes, reduced red cell membrane stiffness, and induced disseminated intravascular coagulation. Inhibition of thrombin formation with argatroban abolished the increase in free hemoglobin concentration, schistocyte formation, and disseminated intravascular coagulation in LPS-treated animals. Eptifibatide had no inhibitory effect. The LPS evoked decrease of red cell stiffness that was not affected by argatroban or eptifibatide. LPS causes hemolysis, schistocyte formation, and red cell mem- brane weakening in rats.
  • WO 2015/073587 A2 21 May 2015 (21.05.2015) P O P CT

    WO 2015/073587 A2 21 May 2015 (21.05.2015) P O P CT

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/073587 A2 21 May 2015 (21.05.2015) P O P CT (51) International Patent Classification: Noubar, B.; c/o Rubius Therapeutics, Inc., 1 Memorial B82Y5/00 (201 1.01) Drive, 7th Floor, Cambridge, MA 02142 (US). (21) International Application Number: (74) Agents: YEE, Gene et al; Fenwick & West LLP, 801 PCT/US2014/065304 California Street, Mountain View, CA 94041 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 12 November 2014 (12.1 1.2014) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, English (25) Filing Language: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (26) Publication Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (30) Priority Data KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, 61/962,867 18 November 2013 (18. 11.2013) US MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, 61/919,432 20 December 201 3 (20. 12.2013) US PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 61/973,764 1 April 2014 (01.04.2014) us SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 61/991,3 19 9 May 2014 (09.05.2014) us TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.